Investigating the Role of Experimental Variables in Characterization of Lidocaine Hydrochloride Cubosomes by QbD

Main Article Content

Chakravarthi Guntupalli

Abstract

Aim: The objective of this research work was to analyze the effect of experimental components (homogenization
time, speed of homogenization, and time of sonication) on the characterization of cubosomes loaded with
Lidocaine Hydrochloride (LH). Materials and Methods: The Top-down method was adopted to prepare LH
cubosomes using lipid (Glyceryl Monooleate), stabilizer (Poloxamer-407) along with water in varied proportions.
32 factorial design was adopted to explain how the two independent factors, that is, homogenization speed and
sonication time affect the four responses at varied levels of the processing parameters for the preparation of
drug-encapsulated cubosomes. Results and Discussion: The most acceptable entrapment capacity was found
at a homogenization speed of 50 rpm and sonication time employed for 10 min for the formulation LT8 within
the confidence intervals adopted by the 32 factorial design. LT8 was found to have Entrapment efficiency (EE)
of 75 percent, Zeta potential of 21.5 mV, vesicle size of 150.3± 0.77 nm, and PolyDispersibility Index of 0.278.
As Hominization speed increased there was a noticeable improvement in the characterization of cubosomes,
however, enhanced characterization parameters were observed in dispersions prepared with a medium level of
sonication time. Conclusion: A steady dispersion of LH was formed with a high level of speed of homogenization
and a medium level of sonication time to attain the desired parameters for the characterization of cubosomes.
Therefore, it is concluded that the speed of homogenization of 50 rpm and sonication time of 10 min resulted in
a stable dispersion.

Downloads

Download data is not yet available.

Article Details

How to Cite
Guntupalli, C. . (2025). Investigating the Role of Experimental Variables in Characterization of Lidocaine Hydrochloride Cubosomes by QbD. Asian Journal of Pharmaceutics (AJP), 19(01). https://doi.org/10.22377/ajp.v19i01.6081
Section
ORIGINAL ARTICLES